These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 24220048)

  • 1. Update on infections in composite tissue allotransplantation.
    Avery RK
    Curr Opin Organ Transplant; 2013 Dec; 18(6):659-64. PubMed ID: 24220048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppression maintenance in vascularized composite allotransplantation: what is just right?
    Howsare M; Jones CM; Ramirez AM
    Curr Opin Organ Transplant; 2017 Oct; 22(5):463-469. PubMed ID: 28759463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascularized composite allotransplantation: current standards and novel approaches to prevent acute rejection and chronic allograft deterioration.
    Kueckelhaus M; Fischer S; Seyda M; Bueno EM; Aycart MA; Alhefzi M; ElKhal A; Pomahac B; Tullius SG
    Transpl Int; 2016 Jun; 29(6):655-62. PubMed ID: 26265179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scabies in a bilateral hand allograft recipient: An additional mimicker of acute skin rejection in vascularized composite allotransplantation.
    Kanitakis J; Morelon E
    Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28211139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascularized composite allotransplantation: towards tolerance and the importance of skin-specific immunobiology.
    Leonard DA; Kurtz JM; Cetrulo CL
    Curr Opin Organ Transplant; 2013 Dec; 18(6):645-51. PubMed ID: 24126805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adipose-derived cellular therapies in solid organ and vascularized-composite allotransplantation.
    Stivers KB; Beare JE; Chilton PM; Williams SK; Kaufman CL; Hoying JB
    Curr Opin Organ Transplant; 2017 Oct; 22(5):490-498. PubMed ID: 28873074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significant infections after hand transplantation in a Polish population.
    Kamińska D; Kościelska-Kasprzak K; Myszka M; Banasik M; Chełmoński A; Boratyńska M; Jabłecki J; Klinger M
    Transplant Proc; 2014 Oct; 46(8):2887-9. PubMed ID: 25380943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infections in composite tissue allograft recipients.
    Hammond SP
    Infect Dis Clin North Am; 2013 Jun; 27(2):379-93. PubMed ID: 23714346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulatory T cells are not predictive of outcomes in a nonhuman primate model of vascularized composite allotransplantation.
    Brazio PS; Munivenkatappa RB; Bojovic B; Ha JS; Brown EN; Hess AS; Bartlett ST; Rodriguez ED; Barth RN
    Transplantation; 2013 Aug; 96(3):267-73. PubMed ID: 23839001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of rejection in vascular composite allotransplantation.
    Etra JW; Raimondi G; Brandacher G
    Curr Opin Organ Transplant; 2018 Feb; 23(1):28-33. PubMed ID: 29189293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization, prophylaxis, and treatment of infectious complications in craniomaxillofacial and upper extremity allotransplantation: a multicenter perspective.
    Broyles JM; Alrakan M; Ensor CR; Khalifian S; Kotton CN; Avery RK; Brandacher G; Lee WPA; Gordon CR
    Plast Reconstr Surg; 2014 Apr; 133(4):543e-551e. PubMed ID: 24675206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascularized composite allografts and solid organ transplants: similarities and differences.
    Weissenbacher A; Hautz T; Pratschke J; Schneeberger S
    Curr Opin Organ Transplant; 2013 Dec; 18(6):640-4. PubMed ID: 24126807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosing skin rejection in vascularized composite allotransplantation: advances and challenges.
    Sarhane KA; Khalifian S; Ibrahim Z; Cooney DS; Hautz T; Lee WP; Schneeberger S; Brandacher G
    Clin Transplant; 2014 Mar; 28(3):277-85. PubMed ID: 24476538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel targeted drug delivery systems to minimize systemic immunosuppression in vascularized composite allotransplantation.
    Taddeo A; Tsai C; Vögelin E; Rieben R
    Curr Opin Organ Transplant; 2018 Oct; 23(5):568-576. PubMed ID: 30074507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased risk of breakthrough infection among cytomegalovirus donor-positive/recipient-negative kidney transplant recipients receiving lower-dose valganciclovir prophylaxis.
    Stevens DR; Sawinski D; Blumberg E; Galanakis N; Bloom RD; Trofe-Clark J
    Transpl Infect Dis; 2015 Apr; 17(2):163-73. PubMed ID: 25661673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic rejection in vascularized composite allotransplantation.
    Morelon E; Petruzzo P; Kanitakis J
    Curr Opin Organ Transplant; 2018 Oct; 23(5):582-591. PubMed ID: 30102615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytomegalovirus infection in renal transplant recipients: one center's experience.
    Bal Z; Uyar ME; Tutal E; Erdogan E; Colak T; Sezer S; Haberal M
    Transplant Proc; 2013; 45(10):3520-3. PubMed ID: 24314948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Donor-specific antibodies and antibody-mediated rejection in vascularized composite allotransplantation.
    Weissenbacher A; Loupy A; Chandraker A; Schneeberger S
    Curr Opin Organ Transplant; 2016 Oct; 21(5):510-5. PubMed ID: 27517505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascularized composite allograft-specific characteristics of immune responses.
    Issa F
    Transpl Int; 2016 Jun; 29(6):672-81. PubMed ID: 26927941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic Rejection in Human Vascularized Composite Allotransplantation (Hand and Face Recipients): An Update.
    Kanitakis J; Petruzzo P; Badet L; Gazarian A; Thaunat O; Testelin S; Devauchelle B; Dubernard JM; Morelon E
    Transplantation; 2016 Oct; 100(10):2053-61. PubMed ID: 27163543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.